Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Annals of the Rheumatic Diseases|March 8, 2011
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosisElizabeth N Le, Fredrick M Wigley, Ami A Shah, et al.
Clinical Rheumatology|May 28, 2018
Vascular complications in systemic sclerosis: a prospective cohort studyChristopher A Mecoli, Ami A Shah, Francesco Boin, et al.
Arthritis Research & Therapy|May 6, 2016
Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in sclerodermaAndrea Fava, Raffaello Cimbro, Fredrick M Wigley, et al.
Arthritis Research & Therapy|August 7, 2015
Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control studyZsuzsanna McMahan, Florian Schoenhoff, Jennifer E Van Eyk, et al.
Clinical and Experimental Rheumatology|August 6, 2015
Pilot study to determine whether transient receptor potential melastatin type 8 (TRPM8) antibodies are detected in sclerodermaAmi A Shah, Janelle Montagne, Sun-Young Oh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 23, 2020
The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal AnalysisChristopher A Mecoli, Ami A Shah, Francesco Boin, et al.
Cureus|September 10, 2019
Clinical Characteristics of Hydralazine-induced LupusHoma Timlin, Michael Wu, Monica Crespo-Bosque, et al.
Ophthalmology|September 3, 2014
Ocular and systemic morbidity in a longitudinal cohort of Sjögren's syndromeEsen Karamursel Akpek, Priya Mathews, Sarah Hahn, et al.
Rheumatology (Oxford, England)|March 9, 2024
Characteristics associated with patient-reported treatment success in psoriatic arthritisChristeen Samuel, Amanda Finney, Thomas Grader-Beck, et al.
The Open Rheumatology Journal|May 10, 2011
Long term effects of cyclophosphamide treatment on lung function and survival in scleroderma patients with interstitial lung diseaseS Mittoo, Fredrick M Wigley, Robert A Wise, et al.
Pageof 16